12th EDRN Scientific Workshop - Tuesday 23 March Agenda
20th Year of EDRN: Making Cancer Detection Possible
Tuesday, March 23, 2021 (9:45 a.m. - 6:10 p.m. Eastern Daylight Time)
|
9:45 a.m. - 9:50 a.m. EDT (all times Eastern Daylight Time) |
Admittance to Workshop via Zoom/General Announcements |
| 9:50 a.m. - 10:05 a.m. EDT |
Welcome and Opening of the March 2021 EDRN Scientific Workshop Joshua LaBaer, MD, PhD, Arizona State University/The Biodesign Institute Arul Chinnaiyan, MD, PhD, University of Michigan Sudhir Srivastava, PhD, MPH, National Cancer Institute |
| 10:05 a.m. - 10:15 a.m. EDT |
Opening Remarks Ned Sharpless, MD, Director, National Cancer Institute |
| 10:15 a.m. - 10:45 a.m. EDT |
01: Life-Time Experience with Cancer Diagnostics Robert Bast, MD, The University of Texas MD Anderson Cancer Center |
| 10:45 a.m. - 1:15 p.m. EDT | Session 1 - Integrated Approaches to Biomarker Research |
| 10:45 a.m. - 10:50 p.m. EDT |
Introduction to the Session Moderators: Denise Aberle, MD, University of California, Los Angeles Hui Zhang, PhD, Johns Hopkins University School of Medicine |
| 10:50 a.m. - 11:10 a.m. EDT |
02: Precision Medicine of Lung Cancer: Metabolome and Microbiome Curt Harris, MD, National Cancer Institute |
| 11:10 a.m. - 11:15 a.m. EDT | Q&A |
| 11:15 a.m. - 11:35 a.m. EDT |
03: Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors Arul Chinnaiyan, MD, PhD, University of Michigan |
| 11:35 a.m. - 11:40 a.m. EDT | Q&A |
| 11:40 a.m. - 11:50 a.m. EDT | Break |
| 11:50 a.m. - 12:10 p.m. EDT |
04: DNA Methylation Detection for Early Lung Cancer Specificity and Universal Cancer Detection using Plasma James Herman, MD, University of Pittsburgh School of Medicine |
| 12:10 p.m. - 12:15 p.m. EDT | Q&A |
| 12:15 p.m. - 12:35 p.m. EDT |
05: The Immunogenicity of Post-Translational Protein Modifications Karen Anderson, MD, PhD, Arizona State University/The Biodesign Institute |
| 12:35 p.m. - 12:40 p.m. EDT | Q&A |
| 12:40 p.m. - 1:10 p.m. EDT |
06: Toward noninvasive early cancer detection using circulating DNA Ash Alizadeh, MD, PhD, Stanford Comprehensive Cancer Center |
| 1:10 p.m. - 1:15 p.m. EDT | Q&A |
| 1:15 p.m. - 1:35 p.m. EDT | Break |
| 1:35 p.m. - 3:45 p.m. EDT | Session 2 - Integrated Approaches to Biomarker Research II |
| 1:35 p.m. - 1:40 p.m. EDT |
Introduction to the Session Moderators: Surinder Batra, PhD, University of Nebraska Medical Center Zhen Zhang, PhD, Johns Hopkins University School of Medicine |
| 1:40 p.m. - 2:00 p.m. EDT |
07: Decoding the Cancer Mucinome Carolyn Bertozzi, PhD, Stanford School of Humanities and Sciences |
| 2:00 p.m. - 2:05 p.m. EDT | Q&A |
| 2:05 p.m. - 2:25 p.m. EDT |
08: Moffitt Imaging Biomarker VAlidation Center (MIBVAC) Matthew Schabath, PhD, H. Lee Moffit Cancer Center and Research Institute |
| 2:25 p.m. - 2:30 p.m. EDT | Q&A |
| 2:30 p.m. - 2:50 p.m. EDT |
09: Multi-Disciplinary Strategies for Cancer Early Detection Victoria Seewaldt, MD, City of Hope |
| 2:50 p.m. - 2:55 p.m. EDT | Q&A |
| 2:55 p.m. - 3:15 p.m. EDT |
10: Integrated approach towards pancreatic cancer biomarker development Anirban Maitra, MBBS, The University of Texas MD Anderson Cancer Center |
| 3:15 p.m. - 3:20 p.m. EDT | Q&A |
| 3:20 p.m. - 3:40 p.m. EDT |
11: A Unique Approach Combining Avatar Mice and Mass Spectrometry to Identify Blood Biomarkers for Early Detection of Breast Cancer Amanda Paulovich, MD, PhD, Fred Hutchinson Cancer Research Center |
| 3:40 p.m. - 3:45 p.m. EDT | Q&A |
| 3:45 p.m. - 4:00 p.m. EDT | Break |
| 4:00 p.m. - 6:10 p.m. EDT | Session 3 - Research Excellence through Alliance of Consortia |
| 4:00 p.m. - 4:05 p.m. EDT |
Introduction to the Session Moderator: Barbara Kenner, PhD, Kenner Family Research Fund |
| 4:05 p.m. - 4:25 p.m. EDT |
12: Using markers to improve pancreatic cancer screening and surveillance Michael Goggins, MD, Johns Hopkins University School of Medicine |
| 4:25 p.m. - 4:30 p.m. EDT | Q&A |
| 4:30 p.m. - 4:50 p.m. EDT |
13: Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer Stephen Pandol, MD, Cedars-Sinai Medical Center |
| 4:50 p.m. - 4:55 p.m. EDT | Q&A |
| 4:55 p.m. - 5:15 p.m. EDT |
14: Translational Liver Consortium Hashem El-Serag, MD, MPH, Baylor College of Medicine |
| 5:15 p.m. - 5:20 p.m. EDT | Q&A |
| 5:20 p.m. - 5:40 p.m. EDT |
15: Exosomes - Rigor and Reproducibility David Lyden, MD, PhD, Weill Cornell Medical College |
| 5:40 p.m. - 5:45 p.m. EDT | Q&A |
| 5:45 p.m. - 6:05 p.m. EDT |
16: Pre-Cancer Atlas Peter Sorger, PhD, Harvard Medical School |
| 6:05 p.m. - 6:10 p.m. EDT | Q&A |
| 6:10 p.m. EDT | Adjourn for the Day |